Skip to main content
. Author manuscript; available in PMC: 2017 Dec 7.
Published in final edited form as: Adv Funct Mater. 2016 Mar 31;26(22):3933–3941. doi: 10.1002/adfm.201505256

Figure 6.

Figure 6

Clonogenic surviving fraction as a function of specific absorption rate for cancer cells (MDA-MB-468) exposed to iron oxide (IO) magnetic nanoparticles without/with the peptide epidermal growth factor (EGF). Unbound/uninternalized nanoparticles were removed prior to field application and the temperature remained constant at 37°C during field application. Increasing SAR has a slight effect on clonogenic survival of cells treated with the non-targeted particles (Field IO), but has a significant effect on clonogenic survival of cells treated with targeted nanoparticles (Field IO-EGF).

Reproduced with permission.[37] Copyright 2011, American Chemical Society.